NEW YORK, April 16 – Transgenomic said Monday it had appointed Gregory Duman as chief financial officer, replacing William Rasmussen, who will stay on as a strategic planner for the company.

Previously, Duman, who has been a member of Transgenomic’s board since March of last year, was the CFO of Artios, a company that provides transaction processing services. He also served as CFO and head of software product development at Transaction Systems Architects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.